Quick Heal Technologies Ltd Falls to 52-Week Low of Rs 195.35

Stock Price Movement and Market Context

On 21 Jan 2026, Quick Heal Technologies Ltd’s stock touched an intraday low of Rs 195.35, representing a 3.0% drop on the day and continuing a downward trend over the past four trading sessions. Over this period, the stock has declined by 11.6%, reflecting sustained selling pressure. The current price is substantially below its 52-week high of Rs 578.70, underscoring the steep correction experienced over the last year.

The stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a persistent bearish trend. This technical positioning suggests limited short-term support levels and highlights the stock’s ongoing weakness relative to its historical price action.

In comparison, the broader market has also faced challenges. The Sensex opened lower at 81,794.65, down 385.82 points (-0.47%), and was trading at 81,908.39 (-0.33%) during the same session. The index has experienced a three-week consecutive decline, losing 4.49% in that period. While the Sensex trades below its 50-day moving average, the 50DMA remains above the 200DMA, indicating some underlying market resilience despite recent volatility.

Financial Performance and Growth Metrics

Quick Heal Technologies Ltd’s financial results have contributed to the stock’s subdued performance. Over the past five years, the company’s net sales have contracted at an annual rate of -0.80%, while operating profit has deteriorated sharply by -179.58%. This negative growth trajectory has weighed heavily on investor sentiment and valuation.

The latest half-yearly results reveal further challenges. Profit after tax (PAT) for the most recent six months stood at Rs 2.40 crore, reflecting a decline of 70.66% compared to the previous period. Additionally, the company’s debtors turnover ratio is at a low 1.57 times, indicating slower collection cycles and potential working capital inefficiencies. Cash and cash equivalents have also diminished to Rs 6.84 crore, the lowest level recorded in recent periods.

Valuation and Risk Considerations

The company’s Mojo Score currently stands at 26.0, with a Mojo Grade of Strong Sell as of 2 Dec 2025, downgraded from a Sell rating. This reflects a deteriorated outlook based on a comprehensive assessment of financial health, growth prospects, and market performance. The Market Cap Grade is rated at 3, indicating a relatively modest market capitalisation compared to peers.

Quick Heal Technologies Ltd’s stock has generated a negative return of 63.22% over the last year, significantly underperforming the Sensex, which posted an 8.00% gain over the same period. Profitability has also declined sharply, with profits falling by 102.3% year-on-year. The company’s earnings before interest, taxes, depreciation and amortisation (EBITDA) are negative, adding to the risk profile of the stock.

Despite these challenges, the company maintains a low average debt-to-equity ratio of zero, indicating minimal leverage. Majority ownership remains with promoters, which may provide some stability in governance and strategic direction.

Comparative Performance and Sectoral Context

Quick Heal Technologies Ltd has underperformed not only the Sensex but also the BSE500 index across multiple time frames, including the last three years, one year, and three months. This underperformance highlights the company’s struggles relative to the broader market and its sector peers within Software Products.

Performance today was in line with the sector, suggesting that the stock’s decline is consistent with sectoral trends, though the magnitude of its fall remains more pronounced. The stock’s current trading levels and technical indicators reflect a cautious market stance amid ongoing headwinds.

Summary of Key Metrics

To summarise, Quick Heal Technologies Ltd’s stock has reached a new 52-week low of Rs 195.35, reflecting a sustained decline over recent months. The company’s financial performance has been subdued, with negative growth in sales and profitability, declining cash reserves, and a low debtor turnover ratio. The stock’s valuation metrics and Mojo Grade indicate a cautious stance, with a Strong Sell rating as of December 2025.

Market conditions have also been challenging, with the Sensex experiencing a three-week losing streak and trading below its 50-day moving average. Quick Heal’s stock has underperformed both the broader market and its sector peers, trading below all major moving averages and exhibiting a negative return of over 63% in the past year.

While the company’s low debt levels and promoter ownership provide some structural stability, the prevailing financial and market indicators suggest a period of consolidation at lower price levels.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →